688217 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Shanghai Rightongene Biotechnology Co., Ltd. engages in the research and development, production, and sale of in vitro diagnostic products. It offers leukemia-related fusion gene, human estimated glomerular filtration rate gene mutation, genotype, human rubella virus, small ureaplasma, herpes simplex virus type 12 nucleic acid, and hepatitis B virus gene mutation detection kits. The company was founded by Hui Xiong on February 17, 2012 and is headquartered in Shanghai, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
688217 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company